Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
September 23, 2021
Raphaël Benoist, Philippe Walker, Karine Allain-Baco, et al.
International Journal of Environmental Research and Public Health
|
March 25, 2022
Palliative Care Needs Assessment in the Population Living in Mayotte: SPMAYOTTE, a Qualitative Study Conducted with 62 Patients, Caregivers and Healthcare Professionals
Raphaël Benoist, Philippe Walker, Karine Allain-Baco, et al.
Nature Structural Biology
|
July 9, 2003
Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation
Fabien M Décaillot, Katia Befort, Dominique Filliol, et al.
Pain Reports
|
February 2, 2019
NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain
Pierre Arsenault, Dan Chiche, William Brown, et al.
The Journal of Pain
|
February 12, 2017
Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist
William Brown, Richard L Leff, Andrew Griffin, et al.
Nature Neuroscience
|
February 19, 2002
Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs
Paola M C Lembo, Eric Grazzini, Thierry Groblewski, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
September 23, 2021
Raphaël Benoist, Philippe Walker, Karine Allain-Baco, et al.
International Journal of Environmental Research and Public Health
|
March 25, 2022
Palliative Care Needs Assessment in the Population Living in Mayotte: SPMAYOTTE, a Qualitative Study Conducted with 62 Patients, Caregivers and Healthcare Professionals
Raphaël Benoist, Philippe Walker, Karine Allain-Baco, et al.
Nature Structural Biology
|
July 9, 2003
Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation
Fabien M Décaillot, Katia Befort, Dominique Filliol, et al.
Pain Reports
|
February 2, 2019
NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain
Pierre Arsenault, Dan Chiche, William Brown, et al.
The Journal of Pain
|
February 12, 2017
Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist
William Brown, Richard L Leff, Andrew Griffin, et al.
Nature Neuroscience
|
February 19, 2002
Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs
Paola M C Lembo, Eric Grazzini, Thierry Groblewski, et al.
Page
of 1